Navigation Links
Women's Health Expert Dr. Susan Lark Featured on Searchbodydetox.com
Date:7/13/2009

Susan Lark, MD, an eminent authority on clinical nutrition and preventive medicine, is now a featured expert on searchbodydetox.com, a new informational Web site devoted to all aspects of whole body cleansing and detoxification.

Potomac, MD (Vocus) July 13, 2009 -- Susan Lark, MD, an eminent authority on clinical nutrition and preventive medicine, is now a featured expert on searchbodydetox.com, a new informational Web site devoted to all aspects of whole body cleansing and detoxification.

On searchbodydetox.com, you can find many of Dr. Lark’s recommendations and advice on a variety of topics and concerns, including environmental toxins, colon cleansing, liver detox, lymph and blood detox, skin detox, detox and weight loss, and nutrition and detox. As with all information and advice found on searchbodydetox.com, Dr. Lark’s content delivers effective answers to targeted detox-related questions, as well as offering a plan of action to help reduce your risk of chemical exposure and toxic build up.

Dr. Lark is a distinguished clinician, author, lecturer, and innovative product developer. A graduate of Northwestern University Medical School, she served on the clinical faculty of Stanford University Medical School from 1981–1983, and taught in Stanford's Primary Care Associate Program in the Division of Family and Community Medicine from 1991–2002. Through her 30 years of clinical experience, Dr. Lark has pioneered the use of self-care treatments such as diet, nutrition, exercise, and stress management techniques in the field of women's health, and has lectured extensively throughout the United States on topics in preventive medicine
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Women's Health Expert Dr. Susan Lark Featured on Searchbloodsugar.com
2. Women's Health Expert Dr. Susan Lark Featured on Searchjointpain.com
3. The Healthcare Scoop Seeks Women's Health, Osteoporosis, Arthritis Stories
4. Better Hearing Institute Joins HHS, Office on Women's Health in Promoting National Women's Health Week and Hearing Health
5. LLE Receives Renewal of Women's Business Enterprise National Council Certification
6. Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors
7. Women's Health Services Announces New Associate
8. Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids
9. Jill Bolte Taylor Keynotes ATSU Women's Wellness Luncheon
10. Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch
11. Kabul Under Virtual Lockdown for International Travelers, Progress Still Evident for Women's Programs
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10New study suggests the brain predicts what eyes in motion will see 55304 1New study suggests the brain predicts what eyes in motion will see 55304 2SRNL automakers to develop high performance wireless sensors networks 9693 1SRNL automakers to develop high performance wireless sensors networks 9693 2SRNL automakers to develop high performance wireless sensors networks 9693 3New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 1New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 3New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 4New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 5